The Latin America, Middle East and Africa Joint Pain Injections Market would witness market growth of 10.6% CAGR during the forecast period (2022-2028).
The orthopedic physician may offer several types of joint pain injections based on the unique treatment plan. Injections epidurals are used to treat spinal discomfort as well as pain in the legs or arms caused by an irritated spinal nerve. Epidural injections, like corticosteroid injections, combine an anesthetic with a corticosteroid. Injecting corticosteroids into the epidural area immediately outside of the spinal cord distinguishes an epidural from a conventional corticosteroid injection.
Sacroiliac injections are comparable to facial joint injections, except that they are administered into the sacroiliac joint, which joins the sacral area of the spine to the pelvis. These injections are intended to treat pain in the sacroiliac joint and lower back buttock, and leg pain. Typically, only one side of the body is affected by discomfort.
The UAE healthcare industry has grown to accommodate both the country's expanding population and its aspiration to establish itself as a major regional center for medical tourism. Healthcare is a key area for the UAE government, according to Vision 2040, and the nation will continue to be a desirable place for the establishment of a regional distribution center for healthcare services.
The World Bank 2012 report estimates that 4.7% of the 336 million people living in the Middle East and Northern Africa (MENA) are over the age of 65. An enormous healthcare burden results from this aging population. This intensifies the local problem of joint discomfort. All of these factors suggest that the joint pain injections market in the area will expand significantly.
The Brazil market dominated the LAMEA Joint Pain Injections Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $186.3 Million by 2028. The Argentina market is showcasing a CAGR of 11.2% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 10.3% during (2022 - 2028).
Based on Injection Type, the market is segmented into Interleukin Inhibitors, Hyaluronic Acid Injections, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Joint Type Channel, the market is segmented into Knee & Ankle, Shoulder & Elbow, Hip Joint, Facet Joints of the Spine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Joint Pain Injections Market is Predict to reach $9.9 Billion by 2028, at a CAGR of 7.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.
By Injection Type
By Distribution Channel
By Joint Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 